data

data

Data shows post-Brexit immigration plans will hurt UK gig economy


Data shows post-Brexit immigration plans will hurt UK gig economy
The Government’s post-Brexit immigration plans are aimed at reducing the number of low skilled workers entering the country.
Along with the farming, catering, nursing and care sectors, it is highly likely that workers in the gig economy will be excluded
from the skilled category.

The proposals are likely to intensify the fall in immigrants coming to the UK to work. According to figures published by the Office
for National Statistics, EU net migration is now less than half the level it was at its peak and more workers from Eastern European
countries are leaving than arriving. This trend is already impacting the UK gig economy.

Ana Andres, co-founder of TidyChoice, a platform for independent cleaners analysed the source of their applications over the
past five years. TidyChoice receives over 10,000 applications annually and is a good proxy for the overall London gig economy.
“The rate of applications from Eastern European nationalities has diminished drastically since the Brexit referendum. Better job
prospects at home, weaker Sterling and Brexit uncertainty are the main reasons for the fall. We have maintained strong growth
in total applications by plugging the gap with ever increasing applications from other countries.

Currently only 40% of our applications come from UK nationals. Without overseas workers, it will be very difficult for us to achieve
our targeted 30-40% annual increase in applications that we need to support business growth and counter natural attrition.

The Government is calling on companies to “adapt and adjust”. We cannot automate in our sector and the pool of UK citizens
seeking cleaning work will quickly dry up. I am worried that without new workers coming to the UK, the sector will shrink and
consumer prices will inevitably increase.”

About TidyChoice
Founded in 2014, by Colin Weston and Ana Andres del Valle, TidyChoice is an online platform, offering home cleaning and
childcare services for London residents. TidyChoice professionals undergo a careful vetting process, to ensure customers can
choose from a trusted and reliable community of housekeepers. Customers can choose their preferred professional and
professionals can choose their own rate, hours and areas of work.

Media Contact Details

Colin Weston, TidyChoice

London, United Kingdom

02081331830

Source link

Exide Showcases GNB Sprinter Battery at Data Centre World Paris


Battery manufacturer Exide Technologies, a global provider of stored electrical energy solutions, is presenting its new GNB Sprinter XP12V4400 battery at Data Centre World, which takes place in Paris on 27-28 November 2019. The battery is specially designed to provide low total cost of ownership, with space savings, easy installation and maintenance, and efficient charging.

The latest Sprinter XP12V440 battery is designed to perform in the modern data center, including large-scale colocation and hyperscale facilities. It is made from a high-purity lead alloy offering high-temperature resistance, and is a proven technology that brings peace of mind to customers. The battery saves considerably on space: up to 15–20% compared with traditional lead-acid batteries, contributing significantly to lower total cost of ownership.

With data centers worldwide moving to higher-power UPS that requires larger blocs, Sprinter XP12V4400 offers an ideal solution. Its high power, compact design and small footprint ensure consistent performance and savings in both installation and maintenance. It offers excellent charge efficiency for reduced charging cost, while its special polypropylene container reduces water vapor emissions and prolongs lifespan.

Exide will also be exhibiting its GNB Sprinter XP and XP FT (Front Terminal) ranges and Marathon M12V 190FT – all of which use AGM technology – as well as its Sonnenschein PowerCycle PC12/180FT, which uses dryfit® Gel technology. The data center market is growing fast with the rise in social media and online streaming, and Exide believes its range of advanced products make it well placed to capitalize on future growth.

Data Centre World Paris takes place in the Parc des Exposition in Paris on 27–28 November. Attendees are invited to visit Exide at Stand G42 to see the launch of the new Sprinter XP12V4400 battery and chat to our representatives about the company’s wide range of products.

“Exide has a strong presence in the data center market in France, working with major UPS system manufacturers and a range of other clients,” said Serge Arbes, Senior Business Director Network Power EMEA at Exide. “We look forward to speaking with new and existing customers at the event, and demonstrating how our technology can deliver within their business. Every GNB battery has been specially designed to provide the lowest total cost of ownership for a particular application, and uses technology that has been deployed in large-scale installations around the world.”

Source link

Gilad Tisona: “Big Data is the Solution for Israel’s Transportation Problems”


There has been recent public debate in Israel regarding the imposing of congestion pricing fees as a solution to Israel’s traffic congestion problems. This is yet another in a series of proposed solutions for the colossal traffic congestion problem in Israel, which includes fantasies of a subway system, carpooling projects and an array of incentives to the public in the form of fines. According to big data entrepreneur Gilad Tisona, the only realistic solution to the traffic congestion problem is harnessing big data to the transport system.

Israel is a startup nation, a technological superpower in the areas of chip manufacturing, applications, cyber and so on. Israel also has leading automotive sector startups. There is no reason not to harness this inventiveness to solve the transportation problems plaguing Israel and the rest of the world.

According to Gilad Tisona, in the era of autonomous vehicles (which is not as far off as we may think) many of the technologies used in the field will be Israeli: sensors all around the vehicle to prevent accidents, information security to will prevent criminals from remotely gaining control of vehicles, and especially the collection of data from car users in order to create databases able to route the trip efficiently (speed of travel) and ensure road safety.

A Wave of Innovation
One interesting technological innovation, for example, comes from Arbe, which has developed a sonar or radar for vehicles, allowing for advanced mapping of the vehicle’s surroundings. Arbe is a world leader in the development of sonar for vehicles, and is close to launching an HD quality radar which is far more advanced than the competition’s, and which is able to work in the most difficult visibility conditions.

Another interesting startup mentioned by Gilad Tisona is Galooli. Galooli has developed a big data analysis system for cars for use in tracking, predicting and monitoring using big data analysis of 40 million data points every day touching on a variety of aspects: energy consumption, driver behavior pattern recognition, air pollution monitoring, hazard prevention, car status and many more advanced things that will characterize the automobile market in the not too distant future.

Only Big Data Can Solve the Traffic Problem in Israel
According to Gilad Tisona, an especially interesting startup is NoTraffic, which has developed an advanced platform for the regulation of traffic using a combination of big data collected from the communication of sensors in the vehicle and at intersections. The system is able to process all of the data uploaded to the cloud from all of the information points, thereby optimizing traffic light times in order to allow for the fastest possible flow of traffic. The company is already active in several locations in the US and has successfully reduced urban travel times by 40%.

According to Gilad Tisona, Israel cannot be expected to find a physical solution to its transportation problem: the paving of bike paths is only slowly being carried out, and doesn’t make much of a difference anyway. The construction of new interchanges doesn’t contribute to the reduction of traffic in practice. The congestion pricing fee is a “punishment” for drivers who have to sit in traffic jams, because they have no alternative solutions, such as efficient and effective public transportation. Therefore, monitoring information from vehicles and using it to efficiently route traffic may be the solution Israel needs to get out of the traffic jam it’s stuck in.

Source link

How TourGame uses big data analytics for eSports in global market


There’s been an explosive growth in esports popularity over recent years, fuelled by mobile games specifically designed with online tournament such as Dota 2 and League of Legend. Many esports communities started to prosper in a digital ecosystem. In the digital esports world, collecting large amounts of structured data is no mean task – but it is worth the effort.

Like any other sport, winning doesn’t just depend on skill, dedication and luck. Strategy and analysis of past performance often play an essential role in success. Data collection, aggregation, and analytics lead to highly scalable business models, especially in a dynamic digital industry. As a result, big data analytics becomes economically relevant in esports.

TourGame, one of the leading gaming and eSports platform provider, has seized the opportunity to enhance their eSports platform with an AI-supported analytic tool to assess hundreds of data points collected from digitally recorded games. With big data analytics in esports, players and teams are able to leverage their information in ways that were not possible before. The tool provides useful statistics, identify weaknesses of competitor players and teams and predict the likelihood of an opponent’s next move in any given situation. Players, coaches and teams are eagerly investing in this tool for valuable information to give them a competitive edge.

Just as data analytics with traditional sports, big data analytics is vital for esports today and in the future. TourGame strives to continue its mission to shape the future of eSports using big data analytics and data protection technology and infrastructure.

Source link

Exide To Present New GNB Sprinter Battery At Data Centre World


Battery manufacturer Exide Technologies, a global provider of stored electrical energy solutions, will present its new GNB Sprinter XP12V4400 battery at the upcoming Data Centre World, which takes place in Frankfurt, Germany, on 13¬–14 November 2019. The battery is specially designed to provide low total cost of ownership, with space savings, easy installation and maintenance, and efficient charging.

“The latest Sprinter XP12V4400 battery is designed to perform in the modern data center, including large-scale colocation and hyperscale facilities. It is made from a high-purity lead alloy offering high-temperature resistance, and is a proven technology that brings peace of mind to customers,“ said Serge Arbes, Senior Business Director Network Power EMEA at Exide. “The battery saves considerably on space: up to 15–20% compared with traditional lead-acid batteries, contributing significantly to lower total cost of ownership.”

With data centers worldwide moving to higher-power UPS that requires larger blocs, Sprinter XP12V4400 offers an ideal solution. Its high power, compact design and small footprint ensure consistent performance and savings in both installation and maintenance. It offers excellent charge efficiency for reduced charging cost, while its special polypropylene container reduces water vapor emissions and prolongs lifespan.

Exide will also be exhibiting its GNB Sprinter XP and XP FT (Front Terminal) ranges and Marathon M12V190FT – all of which use AGM technology – as well as its Sonnenschein PowerCycle PC12/180FT, which uses dryfit Gel technology. Each of these advanced products is designed for particular applications.

Data Centre World Frankfurt takes place in the Frankfurter Messe (trade fair) on 13–14 November. Attendees are invited to visit Exide at Stand 330 to see the launch of the new Sprinter XP12V4400 battery and chat with our representatives about the company’s wide range of products.

Source link

330 delegates, 35 countries… came to Athens to debate the future of medical travel

DSC_9761The IMTJ Medical Travel Summit 2018 , held in Athens, Greece on May 21-24 2018, attracted 330 delegates, exhibitors, sponsors and participants from around the globe. The Summit brought together key opinion leaders and senior executives involved in medical tourism and healthcare businesses across the world to discuss the future of this developing industry sector.

The Summit was co-hosted by Elitour, the Greek Medical Tourism Council.

The Summit addressed many of the issues that face the sector – the future of global healthcare, trends in healthcare and technology, destination development, and the patient experience. Sessions were dedicated to specific areas such as fertility travel, dental travel, and wellness tourism and important international patient markets including Russia and the CIS, and the Gulf. The closing highlight of the event, the Great Debate, conducted in Oxford Union style, considered whether “the medical tourism sector has failed to deliver what its customers need and want”.

According to Keith Pollard, IMTJ Editor in Chief and Executive Chairman of LaingBuisson International:

“The Summit exceeded our expectations not only in the support from delegates and sponsors but also in the quality of content delivered by our speakers. What will continue to differentiate the IMTJ Medical Travel Summit is our commitment to substance, avoiding the hype that has plagued other events in the sector, providing an honest and realistic assessment of the current market and examining the future of medical travel.”

The event was made possible through the support of Korea Health Industry Development Institute (KHIDI), Medical Korea, Poliklinika Bagatin, Zagreb, Hygeia Group, Embryogenesis, IASO, Institute of Life, Athens Medical Group, Dubai Health, Sunway Medical Centre, Intermedika, Enterprise Greece, Elitour – Greek Medical Tourism Council, Greek National Tourism Organisation, Athens Convention & Visitors Bureau, Federation of Hellenic Associations of Tourist & Travel Agencies, Hellenic Association of Travel & Tourist Agencies, SETE – Greek Tourism Confederation, Argo Travel, Aegean, Healthcare Business International, Kathimerini, Russian Media Group, Travelling, Travel Daily News, Greek Travel Pages, Pink Medico

For all media enquiries, including images of the Summit and interviews with Keith Pollard, please contact Sarah Ward: sarahward@imtj.com.

Notes for editors:

About IMTJ

The International Medical Travel Journal provides insight into the medical travel and medical tourism sector. IMTJ was established in 2007 in response to the increasing interest in medical travel and medical tourism. It embraces many of the themes that challenge healthcare providers across the world – insurance, accreditation, marketing and promotion, quality, patient safety, levels of care and experience in treating international patients.

IMTJ is independent of the associations and special interest groups that have come aboard the medical tourism bandwagon. Our aim is to create a central focus for information, resources and opinion on medical travel for those involved in the industry, anywhere in the world.

The internationalisation of healthcare through medical travel is at the heart of IMTJ. Patients are becoming healthcare consumers and in many countries, patient choice is being extended to surgery and treatment provided by international hospitals and clinics. By sharing expertise, knowledge, and views about the health travel industry, IMTJ helps to ensure that patient expectations are met, and that the industry maintains a high reputation.

LaingBuisson

The International Medical Travel Journal (IMTJ) is owned and managed by LaingBuisson International. The company also operates consumer facing portals for medical tourism – Treatment Abroad and Fertility Treatment Abroad .

LaingBuisson is a leading healthcare intelligence provider and has been serving clients for over 30 years with insights, data and analysis of market structures, policy and strategy across healthcare and social care. LaingBuisson is the chosen provider of independent sector healthcare market data to the UK Government Office for National Statistics and works globally with providers, commissioners, payors, manufacturers, investors, regulators and advisors. LaingBuisson helps clients to understand their markets, make informed decisions and deliver better outcomes through market intelligence, consulting and data solutions.

Success in medical travel recognised by IMTJ Medical Travel Awards 2018

DSC_1435The very best in the medical travel sector are celebrating following the announcement of the winners in the IMTJ Medical Travel Awards 2018 .

The awards celebrate innovation and excellence in the medical travel, medical tourism and health tourism industry. Unlike other awards in the sector, the IMTJ awards are judged by an independent panel of medical travel experts, chaired by IMTJ Editor in Chief, Keith Pollard.

The awards were presented on 23 May at a high-profile reception in Athens, Greece during the IMTJ Medical Travel Summit which brought together leading healthcare providers and medical tourism experts from around the world. The Awards were generously supported by Elitour, Medical Korea, the Hellenic Motor Museum, Radisson Blu, Argo Travel and Athens Convention & Visitors Bureau.

The 2018 winners are:

Health and medical tourism: Destination of the year
Korea Health Industry Development Institute

Health and medical tourism: Cluster of the year
Malaysia Healthcare Travel Council

International hospital of the year
Gleneagles Kuala Lumpur, Malaysia

Specialist international patient centre
Institut Jantung Negara (IJN), Malaysia

International dental clinic of the year
Kreativ Dental Clinic, Hungary

International cosmetic surgery clinic of the year
Beverly Wilshire Medical Centre, Malaysia

International fertility clinic of the year
TMC Fertility & Women’s Specialist Centre, Malaysia

International cancer centre of the year
The London Clinic, UK

International hair clinic of the year
DHI Scotland, UK

International eye clinic of the year
Moorfields Eye Hospital Dubai, UAE

Best medical travel web site
Qunomedical, Germany

Best marketing initiative
Gleneagles Kuala Lumpur, Malaysia

Best quality initiative
TMC Fertility & Women’s Specialist Centre, Malaysia

Excellence in customer service
Clemenceau Medical Center, Lebanon

Best use of technology in medical tourism
Clemenceau Medical Center, Lebanon

Highly commended entrants:

Health and medical tourism: Destination of the year
Malaysia Healthcare Travel Council

Excellence in customer service
The London Clinic, UK

Excellence in customer service
Gleneagles Kuala Lumpur, Malaysia

Best medical travel web site
IVF Media, USA

Editor in Chief of IMTJ, Keith Pollard says:

“The IMTJ Medical Travel Awards celebrate outstanding achievement in the medical travel, medical tourism and health tourism industry worldwide, and are the only independent awards to recognise those who are the best of the best. Our panel of 20 international judges wanted to reward innovation and excellence, highlight best practice and celebrate those who are leading the way in the industry and delivering successful outcomes for patients

All of our winners exemplify the way the medical travel industry should operate –offering an exceptional patient experience and providing the best possible medical outcomes. I’m already looking forward to next year’s awards; I encourage other hospitals, clinics and medical travel providers to raise their game to match or even better this year’s winners.”

For all media enquiries, including images of the ceremony, contacts for winners and interviews with Keith Pollard, please contact Sarah Ward: sarahward@imtj.com.

Notes for editors:

About IMTJ

The International Medical Travel Journal provides insight into the medical travel and medical tourism sector. IMTJ was established in 2007 in response to the increasing interest in medical travel and medical tourism. It embraces many of the themes that challenge healthcare providers across the world – insurance, accreditation, marketing and promotion, quality, patient safety, levels of care and experience in treating international patients.

IMTJ is independent of the associations and special interest groups that have come aboard the medical tourism bandwagon. Our aim is to create a central focus for information, resources and opinion on medical travel for those involved in the industry, anywhere in the world.

The internationalisation of healthcare through health tourism is at the heart of IMTJ. Patients are becoming healthcare consumers and in many countries, patient choice is being extended to surgery and treatment provided by international hospitals and clinics. By sharing expertise, knowledge, and views about the health travel industry, IMTJ helps to ensure that patient expectations are met, and that the industry maintains a high reputation.

The International Medical Travel Journal (IMTJ) is owned and managed by LaingBuisson. The company also operates a consumer facing portal for medical tourism – Treatment Abroad.

Global cholesterol-lowering drugs market set to grow to $23bn by 2021

Visiongain’ has launched a new pharma report entitled Global Cholesterol-Lowering Drugs Market 2017-2027: Statins and Fixed-Dose Combinations, Cholesterol Absorption Inhibitors, Ion Exchange Resins, Fibrates, PCSK9 Inhibitors, Novel Drugs.

To read the report Table of contents please click on this link: https://www.visiongain.com/Report/1980/Global-Cholesterol-Lowering-Drugs-Market-2017-2027

Shifting diets and lifestyle choices are associated with increases in wealth and the level of development of a country’s economy. With the rapid growth seen in markets such as the BRIC markets, as well as other nations such as Mexico, rates of high cholesterol have been increasing in these nations. Many of the drugs currently used for the control of cholesterol levels have or are soon going to see their patents expire, allowing for generic competition. This has been particularly prevalent among statins, as many of these were developed some time ago.

There is a strong pipeline for cholesterol-lowering drugs; many of which will launch within the next two to three years. New drug classes such as PCSK9 inhibitors will open up new areas of treatment, as they allow further treatment of patients with very high cholesterol levels. The impact of new treatments will lead to a significant rise in global revenues in the market. The addition of further indications for these new products at a later date would allow for further expansion of their use.

Paraguay-Cholesterol-Lowering-Drugs-Market-Forecast-2017-2027

To request a free report overview please email Sara Peerun: sara.peerun@visiongain.com or call her on +44 207 336 6100

The lead analyst of the report commented “Visiongain believes the major drivers of growth in the global cholesterol-lowering drugs market will be: increasing demand for cholesterol-lowering drugs due to population growth and the increasing prevalence of high cholesterol, improvements in the management and treatment of high cholesterol, increasing healthcare expenditure, especially in a number of emerging economies and he launch of new drugs such as PCSK9 inhibitors”

Leading companies featured in the report include: AstraZeneca, Merck & Co, Pfizer, Kowa Company, Daiichi Sankyo, AbbVie, Novartis, Sanofi, Amgen, Bristol-Myers Squibb (BMS).

You may download free sample pages on this time critical report by clicking on this link:
https://www.visiongain.com/Report/1980/Global-Cholesterol-Lowering-Drugs-Market-2017-2027

To request a free report overview please email Sara Peerun: sara.peerun@visiongain.com or call her on +44 207 336 6100

Companies mentioned in this report include:
Abbott Laboratories
AbbVie
Accord Healthcare
Aegerion Pharmaceuticals
Alcon
Algorithm SAL
Allergan
Alynlam Pharmaceuticals
Amgen
Apotex
Astellas Pharma
AstraZeneca
Aurobindo
BASF
Bayer
Biomarin Pharmaceuticals
Blu Caribe
Bristol-Myers Squibb
Ciba-Geigy
Daiichi Sankyo
DalCor Pharmaceuticals
Dezima Pharma
Dr Reddy’s Laboratories
EGIS Pharmaceuticals
Eli Lilly
Esperion Therapeutics
Eisai
Fresenius Medical Care
Genzyme Corporation
Glenmark
Hetero Laboratories
Impax Laboratories
Intas Pharmaceuticals
Isis Pharmaceuticals
JW Pharmaceutical
Kaneka
Kowa
Kremers Urban Pharmaceuticals
Lek
Lupin
Merck and Co.
Micro Laboratories
Miltenyi-Biotec
Mylan
Novartis
Par Pharmaceuticals
Pfizer
ProEthic Pharmaceuticals
ProNova BioPharma
Ranbaxy
Reckitt Benckiser
Recordati
Regeneron
Roche
Sandoz
Sanofi
Serometrix
Shionogi
Solvay
Sun Pharma
Teva
Torrent Pharmaceuticals
UCB
Valeant
Warner-Lambert
Wockhardt
Zydus Cadila

Notes for Editors

If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain

Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.